Abstract

BackgroundA prospective Drug Utilization Review (DUR) program has been implemented in Korea to improve the quality and safety of medication use.ObjectiveTo evaluate the influence of the DUR program in reducing incidence of preventable adverse drug reactions (pADRs).MethodsThis study was performed using administrative data from the Health Insurance Review and Assessment Service (HIRA). The claims data for all adult patients with adverse drug events (ADE)-related diagnoses from 2009 to 2014 were obtained. Incidence rates of first-time and repeat pADRs prior to and after DUR program implementation were evaluated. Quarterly trends in incidence rates of overall ADE, allergic reactions, and ADRs were analyzed.ResultsData extraction covering the period from 2009 to 2014 led to the identification of 3,927,662 records. First-time pADR rates decreased gradually after implementation of the DUR program (change in slope: -0.016, p = 0.02). The program had a similar influence on repeat pADR rates (change in slope: -0.006, p≤0.01). The program did not decrease rates of first-time or repeat allergic reactions (change in slope: 0.018, p = 0.07 and 0.003, p = 0.04, respectively). In the cohort aged ≤65 years, first-time pADR rate reduction was significant (28.2% [27.1–29.3] in ≤18 years, and 19.8% [18.1–21.5] in 19–64 years). In contrast, first-time pADR rate was increased by 0.6% [-0.7–1.9] in patients ≥65 years.ConclusionImplementation of the prospective DUR program effectively reduced the number of pADRs. In the future, to reduce non-preventable ADRs such as allergic reactions, provision of clinical information including allergy history should be added to the DUR program.

Highlights

  • An adverse drug event (ADE) is defined as “an injury resulting from medical intervention related to a drug” [1]

  • The program had a similar influence on repeat preventable adverse drug reaction (pADR) rates

  • Implementation of the prospective Drug Utilization Review (DUR) program effectively reduced the number of pADRs

Read more

Summary

Introduction

An adverse drug event (ADE) is defined as “an injury resulting from medical intervention related to a drug” [1]. The term encompasses harms that occur in any health care setting that are directly due to the drug including but not limited to medication errors, adverse drug reactions (ADRs), allergic reactions, and overdoses [2]. It is critical to minimize the potential consequences of ADEs. a large majority of medical errors and ADRs are preventable, numerous studies have reported that ADRs are associated with clinically significant morbidity and mortality, and are a serious threat to public health [3,4,5]. Another study reviewed ADEs in the elderly, and showed that 23.1% of emergency department admissions were found to be ‘probably’ or ‘possibly’ medication-related (13.1% and 10.0%, respectively) [5]. Medication-related adverse events leading people to seek medical care are common in all populations, including special populations

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call